Company Overview and News
Predictive Discovery Ltd (ASX:PDI) has started a diamond drilling program, targeting high-grade gold mineralisation at its Kokoumbo Project in Cote d’Ivoire.
RGORF EDVVF EDVMF EVR GOLD RRS PDI EDV GOLD
2018-08-02 seekingalpha - 3
Good morning. My name is Leonie, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Sandstorm Gold Limited Second Quarter Results Conference Call. All lines have been placed on mute to prevent any background noise.
ICG RIO RIO YRI MEAOF NXXGD BTR ICGQF RTPPF MUX.RTWI NXXGF AUY EDVVF RTNTF MUX EDV WPM SAND SSL SDDXF MUX NXS EDVMF SNXZF RGLD RIO EVR RGL
2018-07-16 accesswire - 1
VANCOUVER, BC / ACCESSWIRE / July 16, 2018 / Sandstorm Gold Ltd. ("Sandstorm Gold Royalties,'' "Sandstorm" or the "Company") (NYSE American: SAND; TSX: SSL) is pleased to provide an update related to share repurchases under the Company's Normal Course Issuer Bid ("NCIB"), recent developments from the Company's royalty portfolio, as well as the acquisition of eight royalties on exploration-staged properties.
YRI KGI.DB MALRY MEAOF AU NXXGD MIN AULGF NXXGF AUY EDVVF AGG KL EDV SSL SAND SDDXF KGI NXS KGI.DB.A EDVMF SNXZF EQXGF EVR MALRF ERDCF
Orezone just released an Updated Feasibility Study highlighting their Bomboré project as possessing: strong economics, modest CapEx, quick payback, simple mine plan, and ample remaining development/exploration upside potential.
ORZCF WFRSF BTG WAF EDVVF EDVMF EVR OCR EDV ORE
George Town, July 12th, 2018 - Endeavour Mining (TSX:EDV) (OTCQX:EDVMF) provides notice that it will release its financial results for the second quarter of 2018 on Wednesday, August 1st, before TSX market open. Management invites you to participate in a conference call and live webcast on the same day at 8:30am (EST) to discuss the Company's financial and operational results.
EDVVF EDVMF EVR EDV
George Town, 26 June, 2018 - Endeavour Mining Corporation (TSX:EDV)(OTCQX:EDVMF) is pleased to announce that all the proposed resolutions at its Annual General Meeting of Shareholders held on Tuesday, June 26, 2018 were duly passed.
EDVVF EDVMF EVR EDV
Leagold should produce 420,000-475,000 toz gold at an AISC around $930/toz in 2018, however, its production should grow to the 700,000 toz level by 2020.
OCANF SCGLF AUY YRI EDVVF EDVMF SCGLY EVR GLE GG HTXFF EDV
2018-06-01 seekingalpha - 2
Below is a list of 10 quality gold producers. I have selected them as the best risk/reward leveraged gold stocks. All of these should outperform the price of gold if it rises. In fact, I expect all of these stocks to double in value if gold reaches $1,600. These are the stocks that you want to own if you are looking for high returns if gold prices start trending. Also, if you are looking for a way to hedge against a market crash, then these stocks offer a potential hedge.
NGDAF ARNGF NGD TGD MUX.RTWI HUMRF DGC EDVVF PMNXF GCM.WT.A PRU MUX AR HTXFF HUM EDV RPM NGD ALO MUX TPWRF WDO EDVMF RPMGD DRGDF RPMGF PRU TPRFF GCM TMM EVR WDOFF
2018-06-01 seekingalpha - 1
Here's a monthly recap of the top news in the gold mining sector, including acquisitions and takeover announcements, financial results and other relevant updates, to keep readers up-to-date on news in the sector. Here's my last update for April if you missed it.
ARCTF LUNMF NSRPF NEM YRI KGI.DB CG LUNCF MAX TMMFF NXXGD NSU CAGDF RSG AMI NXXGF AUY EDVVF RMGGF MDRPF IAG KL ABX EDV SAND SSL ABX SDDXF KGI NXS KGI.DB.A EDVMF NVO SNXZF ORG LUN TMR RMGGY EVR CANWF
In my opinion, the company is heading in the right direction: Sabodala performs well and the Wahgnion gold project in Burkina Faso is entering the development stage.
KGI KGI.DB.A RGORF KGI.DB EDVMF GRY GOLD RRS GPHYF GOLD TGZ TGZ EDVVF EVR KL EDV GSC
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET